USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 12.11.2026 (heute)
| Unternehmen | Anz. Insider | Vol. Käufe | Vol. Verkäufe | Differenz ↓ |
|---|---|---|---|---|
| Leonabio, Inc. | 1 | 9.919.161.281 $ | 0 $ | 9.919.161.281 $ |
| XCF Global, Inc. | 1 | 142.083.451 $ | 0 $ | 142.083.451 $ |
| Rollins Inc. | 2 | 99.913.331 $ | 0 $ | 99.913.331 $ |
| 2023 ETF Series Trust | 1 | 69.662.558 $ | 0 $ | 69.662.558 $ |
| Bambusa Therapeutics, Inc. | 3 | 58.639.957 $ | 0 $ | 58.639.957 $ |
| Lyell Immunopharma, Inc. | 2 | 49.999.983 $ | 0 $ | 49.999.983 $ |
| Corebridge Financial, Inc. | 2 | 156.996.941 $ | 110.032.293 $ | 46.964.648 $ |
| Knot Offshore Partners LP | 1 | 43.499.993 $ | 0 $ | 43.499.993 $ |
| John Hancock Ga Senior Loan Trust | 2 | 43.199.577 $ | 0 $ | 43.199.577 $ |
| Stride, Inc. | 2 | 39.585.245 $ | 0 $ | 39.585.245 $ |
| Pampa Energy Inc. | 3 | 39.250.119 $ | 0 $ | 39.250.119 $ |
| Keenova Therapeutics plc | 1 | 38.722.653 $ | 0 $ | 38.722.653 $ |
| Lycia Therapeutics, Inc. | 1 | 38.522.394 $ | 0 $ | 38.522.394 $ |
| Aspen Neuroscience, Inc. | 2 | 37.999.995 $ | 0 $ | 37.999.995 $ |
| Hamilton Lane Venture Capital & Growth Fund | 1 | 35.000.171 $ | 0 $ | 35.000.171 $ |
| Madrigal Pharmaceuticals, Inc. | 2 | 35.023.032 $ | 430.800 $ | 34.592.232 $ |
| Coursera, Inc. | 1 | 31.450.844 $ | 0 $ | 31.450.844 $ |
| MSC Industrial Direct Co. Inc. | 2 | 29.034.299 $ | 0 $ | 29.034.299 $ |
| Global X Venture & Innovation Fund | 1 | 25.000.000 $ | 0 $ | 25.000.000 $ |
| Lincoln Bain Capital Total Credit Fund | 1 | 25.000.000 $ | 0 $ | 25.000.000 $ |
| Group 1 Automotive Inc. | 3 | 24.232.209 $ | 659.766 $ | 23.572.443 $ |
| Gamestop Corp. | 1 | 22.774.728 $ | 0 $ | 22.774.728 $ |
| Rapport Therapeutics, Inc. | 8 | 22.023.904 $ | 64.448 $ | 21.959.457 $ |
| Kodiak Sciences Inc. | 2 | 24.340.836 $ | 2.700.322 $ | 21.640.514 $ |
| Partners Group Growth, LLC | 1 | 19.978.119 $ | 0 $ | 19.978.119 $ |
| Pepsico Inc. | 2 | 23.686.389 $ | 4.053.891 $ | 19.632.498 $ |
| SIX Flags Entertainment Corporation | 3 | 15.066.320 $ | 0 $ | 15.066.320 $ |
| Kinder Morgan, Inc. | 3 | 14.994.200 $ | 244.353 $ | 14.749.847 $ |
| Bluerock Private Real Estate Fund | 3 | 13.611.714 $ | 0 $ | 13.611.714 $ |
| Borr Drilling Ltd. | 2 | 13.243.300 $ | 0 $ | 13.243.300 $ |
| Scholar Rock Holding Corp. | 1 | 11.999.922 $ | 0 $ | 11.999.922 $ |
| Iambic Therapeutics, Inc. | 1 | 11.500.000 $ | 0 $ | 11.500.000 $ |
| Galaxy Digital Inc. | 3 | 9.934.246 $ | 197.424 $ | 9.736.822 $ |
| Intel Corp. | 1 | 9.709.680 $ | 0 $ | 9.709.680 $ |
| Electra Therapeutics, Inc. | 2 | 8.699.294 $ | 0 $ | 8.699.294 $ |
| Dole plc | 2 | 8.554.410 $ | 763 $ | 8.553.647 $ |
| GOLD.COM, Inc. | 1 | 6.629.742 $ | 0 $ | 6.629.742 $ |
| Rent the Runway, Inc. | 3 | 6.120.516 $ | 0 $ | 6.120.516 $ |
| City Therapeutics, Inc. | 2 | 6.120.000 $ | 0 $ | 6.120.000 $ |
| Applied Digital Corp. | 3 | 6.664.686 $ | 682.500 $ | 5.982.186 $ |
| Blackstone Private Real Estate Credit & Income Fund | 2 | 5.452.453 $ | 0 $ | 5.452.453 $ |
| Annovis Bio, Inc. | 1 | 5.000.000 $ | 0 $ | 5.000.000 $ |
| Liberty Global Ltd. | 3 | 4.486.300 $ | 0 $ | 4.486.300 $ |
| Third Point Private Capital Income Fund | 1 | 4.000.000 $ | 0 $ | 4.000.000 $ |
| MP Materials Corp. / de | 3 | 3.353.606 $ | 0 $ | 3.353.606 $ |
| Prothena Corp. Public Ltd. Co. | 1 | 3.336.252 $ | 0 $ | 3.336.252 $ |
| TXO Partners, L.P. | 1 | 3.078.749 $ | 0 $ | 3.078.749 $ |
| Frazier Life Sciences Acquisition Corp. II | 1 | 3.000.000 $ | 0 $ | 3.000.000 $ |
| Natures Sunshine Products Inc. | 1 | 2.849.811 $ | 0 $ | 2.849.811 $ |
| Spaccircle Acquisition Corp. | 1 | 2.665.900 $ | 0 $ | 2.665.900 $ |
Seite 1 von 24 · 1173 Unternehmen